Prevalence and Predictors of Potential Drug-Drug Interactions in the Elderly: A Cross-Sectional Study in the Brazilian Primary Public Health System

被引:37
作者
Obreli Neto, Paulo Roque [1 ]
Nobili, Alessandro [2 ,3 ]
Marusic, Srecko [4 ]
Pilger, Diogo [5 ]
Guidoni, Camilo Molino [6 ]
Baldoni, Andre de Oliveira [6 ]
Cruciol-Souza, Joice Mara [7 ]
da Cruz, Alessandra Negri [8 ]
Gaeti, Walderez Penteado [1 ]
Nakamura Cuman, Roberto Kenji [1 ]
机构
[1] Univ Estadual Maringa, Dept Pharmacol & Therapeut, Maringa, Parana, Brazil
[2] Ist Ric Farmacol, Lab Qual Assessment Geriatr Therapies & Serv, Milan, Italy
[3] Ist Ric Farmacol, Drug Informat Serv Elderly, Milan, Italy
[4] Univ Hosp Dubrava, Dept Clin Pharmacol, Zagreb, Croatia
[5] Univ Fed Bahia, Dept Med, Salvador, BA, Brazil
[6] Univ Sao Paulo, Dept Pharmaceut Sci, Ribeirao Preto, SP, Brazil
[7] Univ Estadual Londrina, Dept Pharmaceut Sci, Londrina, PR, Brazil
[8] Fac Integradas Ourinhos, Dept Pharm, Ourinhos, SP, Brazil
关键词
MEDICAL PATIENTS; BEERS CRITERIA; CARE; OUTPATIENTS; DISEASE; POPULATION; EXPOSURE; THAILAND; AGE;
D O I
10.18433/J37K5W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The primary objective of this study was to investigate the prevalence of clinically important potential drug-drug interactions (DDIs) in elderly patients attending the public primary health care system in Brazil. The secondary objective was to investigate possible predictors of potential DDIs. Methods. A cross-sectional study was carried out in 5 Brazilian cities located in the Ourinhos Micro-region, Sao Paulo State, between November 2010 and April 2011. The selected sample was divided according to the presence (exposed) or absence (unexposed) of one or more potential DDIs (defined as the presence of a minimum 5-day overlap in supply of an interacting drug pair). Data were collected from medical prescriptions and patients' medical records. Potential DDIs (rated major or moderate) were identified using 4 DDI-checker programs. Logistic regression analysis was used to study potential DDI predictors. Results. The prevalence of clinically important potential DDIs found during the study period was 47.4%. Female sex (OR = 2.49 [95% CI 2.29-2.75]), diagnosis of = 3 diseases (OR = 6.43 [95% CI 3.25-12.44]), and diagnosis of hypertension (OR = 1.68 [95% CI 1.23-2.41]) were associated with potential DDIs. The adjusted OR increased from 0.90 [95% CI 0.82-1.03] in patients aged 60 - 64 years to 4.03 [95% CI 3.79 - 4.28] in those aged 75 years or older. Drug therapy regimens involving = 2 prescribers (OR = 1.39 [95% CI 1.17-1.67]), = 3 drugs (OR = 3.21 [95% CI 2.78-3.59]), = 2 ATC codes (OR = 1.19 [95% CI 1.12-1.29]), = 2 drugs acting on cytochrome P450 (OR = 2.24 [95% CI 2.07-2.46]), and ATC codes B (OR = 1.89 [95% CI 1.05-2.08]) and C (OR = 4.01 [95% CI 3.55-4.57]) were associated with potential DDIs. Conclusion. Special care should be taken with the prescription and therapeutic follow-up of patients who present characteristics identified as predictors. Knowledge of potential DDI predictors could aid in developing preventive practices and policies that allow public health services to better manage this situation.
引用
收藏
页码:344 / 354
页数:11
相关论文
共 38 条
[1]  
Abarca Jacob, 2004, J Am Pharm Assoc (2003), V44, P136, DOI 10.1331/154434504773062582
[2]  
[Anonymous], MICR HEALTHC SER
[3]  
[Anonymous], 2011, DRUG INT CHECK
[4]   Exposure to potential drug interactions in primary health care [J].
Bjerrum, L ;
Andersen, M ;
Petersen, G ;
Kragstrup, J .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2003, 21 (03) :153-158
[5]   USE OF DRUGS THAT ACT ON THE CYTOCHROME P450 SYSTEM IN THE ELDERLY [J].
Cabrera, Marcos A. S. ;
Dip, Renata M. ;
Furlan, Maira O. ;
Rodrigues, Sara L. .
CLINICS, 2009, 64 (04) :273-278
[6]   Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies [J].
Caccia, Silvio ;
Garattini, Silvio ;
Pasina, Luca ;
Nobili, Alessandro .
DRUG SAFETY, 2009, 32 (11) :1017-1039
[7]   Hepatic cytochrome P450 regulation in disease states [J].
Cheng, PY ;
Morgan, ET .
CURRENT DRUG METABOLISM, 2001, 2 (02) :165-183
[8]   Gaps in the continuity of care and progress on patient safety [J].
Cook, RI ;
Render, M ;
Woods, DD .
BRITISH MEDICAL JOURNAL, 2000, 320 (7237) :791-794
[9]   POTENTIAL-DRUG INTERACTIONS IN AN AMBULATORY GERIATRIC POPULATION [J].
COSTA, AJ .
FAMILY PRACTICE, 1991, 8 (03) :234-236
[10]  
Cruciol-Souza JM, 2006, J PHARM PHARM SCI, V9, P427